Drug Design and Discovery in Alzheimer’s Disease

by

Atta-ur-Rahman, Mohammad Iqbal Choudhary

DOI: 10.2174/97816080582281150101
eISBN: 978-1-60805-822-8, 2014
ISBN: 978-1-60805-823-5
ISSN: 1574-0889 (Print)
ISSN: 2212-1064 (Online)



Indexed in: Book Citation Index, Science Edition, BIOSIS Previews, Scopus, EMBASE, EBSCO, Ulrich's Periodicals Directory.

“Frontiers in Drug Design and Discovery” is an Ebook series devoted to publishing the latest and the most important advances in drug d...[view complete introduction]
US $
Buy Personal eBook
165
Order Library eBook
660
Order Printed Copy
*235
Order PDF + Printed Copy (Special Offer)
*317

*(Excluding Mailing and Handling)

🔒Secure Checkout Personal information is secured with SSL technology
Download Flyer

Combining BACE1 Inhibition with Metal Chelation as Possible Therapy for Alzheimer’s Disease

- Pp. 547-565 (19)

Maged M. Henary, Tyler L. Dost, Eric A. Owens and Surendra Reddy Punganuru

Abstract

A complex disease such as Alzheimer’s requires an arsenal of therapies to help combat and stabilize its advancement. Despite considerable scientific progress, current therapeutic approaches for Alzheimer’s treatment offer only limited and transient benefits to patients. Therefore, in response to the molecular complexity of this disease, a new strategy has recently emerged aimed at simultaneously targeting multiple pathological processes involved in the pathogenesis cascade. β-secretase plays a critical role in β-amyloid formation, a major constituent of amyloid plaques in Alzheimer’s disease (AD) brain and is likely to play a central role in the pathogenesis of this devastating neurodegenerative disorder. Thus, β-secretase is a prime drug target for the therapeutic inhibition of β-amyloid production in AD. It has been clearly established in a number of studies that metal ions are critically involved in the pathogenesis and progression of major neurological diseases (Alzheimer's, Parkinson's). Metal ion chelators have been suggested as potential therapies for diseases involving metal ion imbalance. This chapter summarizes the current therapeutic strategies based on the β-secretase inhibition, metal chelation and their combination to treat AD.

Purchase Chapter  Book Details

Advertisement


Webmaster Contact: info@benthamscience.net Copyright © 2019 Bentham Science